NEAT1 and atherosclerosis: Interestingly, lncRNA MALAT1 and NEAT1 have been found to serve as novel immunoregulators affecting monocyte‐macrophage functions and their disruption may contribute to identifying high risk in post‐MI and atherosclerosis patients.93, 94